169 related articles for article (PubMed ID: 31038909)
1. Light-Activatable Prodrug and AIEgen Copolymer Nanoparticle for Dual-Drug Monitoring and Combination Therapy.
Wu P; Wang X; Wang Z; Ma W; Guo J; Chen J; Yu Z; Li J; Zhou D
ACS Appl Mater Interfaces; 2019 May; 11(20):18691-18700. PubMed ID: 31038909
[TBL] [Abstract][Full Text] [Related]
2. Light-activatable dual prodrug polymer nanoparticle for precise synergistic chemotherapy guided by drug-mediated computed tomography imaging.
Wang Z; Kuang G; Yu Z; Li A; Zhou D; Huang Y
Acta Biomater; 2019 Aug; 94():459-468. PubMed ID: 31128323
[TBL] [Abstract][Full Text] [Related]
3. Stimuli-responsive polymer-doxorubicin conjugate: Antitumor mechanism and potential as nano-prodrug.
Chen K; Cai H; Zhang H; Zhu H; Gu Z; Gong Q; Luo K
Acta Biomater; 2019 Jan; 84():339-355. PubMed ID: 30503561
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional nanogel engineering with redox-responsive and AIEgen features for the targeted delivery of doxorubicin hydrochloride with enhanced antitumor efficiency and real-time intracellular imaging.
Ma Y; Zhou H; Hu F; Pei Z; Xu Y; Shuai Q
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S900-S910. PubMed ID: 30371105
[TBL] [Abstract][Full Text] [Related]
5. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
[TBL] [Abstract][Full Text] [Related]
6. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
[TBL] [Abstract][Full Text] [Related]
7. Drug Delivery Nanoparticles with Locally Tunable Toxicity Made Entirely from a Light-Activatable Prodrug of Doxorubicin.
Schutt C; Ibsen S; Zahavy E; Aryal S; Kuo S; Esener S; Berns M; Esener S
Pharm Res; 2017 Oct; 34(10):2025-2035. PubMed ID: 28791550
[TBL] [Abstract][Full Text] [Related]
8. Self-Assembling Doxorubicin Prodrug Forming Nanoparticles and Effectively Reversing Drug Resistance In Vitro and In Vivo.
Mao X; Si J; Huang Q; Sun X; Zhang Q; Shen Y; Tang J; Liu X; Sui M
Adv Healthc Mater; 2016 Oct; 5(19):2517-2527. PubMed ID: 27529558
[TBL] [Abstract][Full Text] [Related]
9. ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy.
Pei P; Sun C; Tao W; Li J; Yang X; Wang J
Biomaterials; 2019 Jan; 188():74-82. PubMed ID: 30336287
[TBL] [Abstract][Full Text] [Related]
10. AIE Supramolecular Assembly with FRET Effect for Visualizing Drug Delivery.
Dong Z; Bi Y; Cui H; Wang Y; Wang C; Li Y; Jin H; Wang C
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23840-23847. PubMed ID: 31251019
[TBL] [Abstract][Full Text] [Related]
11. One-pot synthesis of hollow PDA@DOX nanoparticles for ultrasound imaging and chemo-thermal therapy in breast cancer.
Zhang T; Jiang Z; Xve T; Sun S; Li J; Ren W; Wu A; Huang P
Nanoscale; 2019 Nov; 11(45):21759-21766. PubMed ID: 31482919
[TBL] [Abstract][Full Text] [Related]
12. pH-sensitive doxorubicin-conjugated prodrug micelles with charge-conversion for cancer therapy.
Ma B; Zhuang W; Wang Y; Luo R; Wang Y
Acta Biomater; 2018 Apr; 70():186-196. PubMed ID: 29452272
[TBL] [Abstract][Full Text] [Related]
13. Mussel-Derived, Cancer-Targeting Peptide as pH-Sensitive Prodrug Nanocarrier.
Ma Y; He P; Tian X; Liu G; Zeng X; Pan G
ACS Appl Mater Interfaces; 2019 Jul; 11(27):23948-23956. PubMed ID: 31192575
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen Peroxide and Glutathione Dual Redox-Responsive Nanoparticles for Controlled DOX Release.
Chen R; Ma Z; Xiang Z; Xia Y; Shi Q; Wong SC; Yin J
Macromol Biosci; 2020 Feb; 20(2):e1900331. PubMed ID: 31856396
[TBL] [Abstract][Full Text] [Related]
15. A pH-sensitive hyaluronic acid prodrug modified with lactoferrin for glioma dual-targeted treatment.
Yin Y; Fu C; Li M; Li X; Wang M; He L; Zhang LM; Peng Y
Mater Sci Eng C Mater Biol Appl; 2016 Oct; 67():159-169. PubMed ID: 27287110
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticles based on star polymers as theranostic vectors: endosomal-triggered drug release combined with MRI sensitivity.
Li Y; Duong HT; Laurent S; MacMillan A; Whan RM; Elst LV; Muller RN; Hu J; Lowe A; Boyer C; Davis TP
Adv Healthc Mater; 2015 Jan; 4(1):148-56. PubMed ID: 24985790
[TBL] [Abstract][Full Text] [Related]
17. Reduction/photo dual-responsive polymeric prodrug nanoparticles for programmed siRNA and doxorubicin delivery.
Wu M; Li J; Lin X; Wei Z; Zhang D; Zhao B; Liu X; Liu J
Biomater Sci; 2018 May; 6(6):1457-1468. PubMed ID: 29770812
[TBL] [Abstract][Full Text] [Related]
18. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
[TBL] [Abstract][Full Text] [Related]
19. Mesoporous silica nanoparticles combining Au particles as glutathione and pH dual-sensitive nanocarriers for doxorubicin.
Xu S; Li Y; Chen Z; Hou C; Chen T; Xu Z; Zhang X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():258-264. PubMed ID: 26652372
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]